Soleus Capital Management, L.P. Lantheus Holdings, Inc. Transaction History

Soleus Capital Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $5.43 Million - $9.42 Million	113,700 New	113,700 $9.39 Million
Q2 2022 Aug 15, 2022	SELL	$55.54 - $72.65 $6.84 Million - $8.95 Million	-123,205 Reduced 69.05%	55,222 $3.65 Million
Q1 2022 May 16, 2022	SELL	$24.28 - $56.64 $38.5 Million - $89.8 Million	-1,586,200 Reduced 89.89%	178,427 $9.87 Million
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $12.1 Million - $16.3 Million	534,800 Added 43.49%	1,764,627 $51 Million
Q3 2021 Nov 15, 2021	BUY	$24.23 - $28.59 $7.66 Million - $9.04 Million	316,130 Added 34.6%	1,229,827 $31.6 Million
Q2 2021 Aug 16, 2021	SELL	$19.51 - $27.64 $1.05 Million - $1.48 Million	-53,675 Reduced 5.55%	913,697 $25.3 Million
Q1 2021 May 17, 2021	BUY	$13.77 - $21.66 $3.1 Million - $4.88 Million	225,287 Added 30.36%	967,372 $20.7 Million
Q4 2020 Feb 16, 2021	BUY	$10.75 - $14.91 $2.5 Million - $3.47 Million	232,541 Added 45.64%	742,085 $10 Million
Q3 2020 Nov 13, 2020	BUY	$11.98 - $16.34 $6.1 Million - $8.33 Million	509,544 New	509,544 $6.46 Million

509

67.3M

1.19M

837K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.52B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.